Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 22,901,784 $ 19,444,737
Accounts receivable 19,566 7,118
Prepaid expenses 898,186 303,178
Other current assets 598,442 576,660
Total Current Assets 24,417,978 20,331,693
Property and equipment, net 5,081,207 5,171,134
Operating lease right-of-use assets 263,440 326,085
Intangible assets, net 240,954 321,641
Total Assets 30,003,579 26,150,553
Current Liabilities    
Accounts payable 1,181,917 1,539,547
Accrued liabilities 3,607,809 3,491,740
Management and directors' fees payable 91,213 55,174
Current portion of long-term debt 759,507 841,319
Current portion of finance lease liabilities 51,950 59,930
Current portion of operating lease liabilities 124,872 179,624
Current portion of grant repayable 34,731 69,218
Total Current Liabilities 5,851,999 6,236,552
Long-term debt, net of current portion 2,027,882 2,606,885
Finance lease liabilities, net of current portion 532,301 601,967
Operating lease liabilities, net of current portion 143,998 151,828
Grant repayable, net of current portion 266,813 259,603
Total Liabilities 8,822,993 9,856,835
STOCKHOLDERS' EQUITY    
Common Stock Authorized: 100,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 53,223,761 shares and 48,607,017 shares, respectively 53,224 48,607
Additional paid-in capital 150,221,335 126,526,239
Accumulated other comprehensive income (loss) 8,732 (59,978)
Accumulated deficit (128,953,498) (110,173,971)
Total VolitionRx Limited Stockholders' Equity 21,329,793 16,340,897
Non-controlling interest (149,207) (47,179)
Total Stockholders' Equity 21,180,586 16,293,718
Total Liabilities and Stockholders' Equity $ 30,003,579 $ 26,150,553